-->

Tag: Iclusig for Ph+ ALL

Home / Iclusig for Ph+ ALL

Categories

Ponatinib with chemotherapy has received accelerated approval by the USFDA for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

March 2024: Ponatinib (Iclusig, Takeda Pharmaceuticals U.S.A., Inc.) has received fast approval from the Food and Drug Administration for use in combination with chemotherapy in adult patients who hav...
iclusig-for-ph-all

Scan the code